CLINICAL_TRIALS
trial_result
· 2022-06-28
Clinical Trial Update: Neuroimaging Reward, Behavioral Treatment, and Smoking Cessation [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial investigating neuroimaging-guided reward and behavioral treatment for smoking cessation has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Maggie M Sweitzer, PhD | Conditions: Smoking | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-28